Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05110963 · ClinicalTrials.gov registry record · NA
Intervention to Improve HIV Care Retention by Addressing Stigma Stigmatized Environments
A NA study of HIV I Infection, sponsored by University of Connecticut.
- Active
- Registry status
- NA
- Development phase
- 3,771
- Enrollment target
- 2
- Study locations
NCT05110963: Active NA study of HIV I Infection, sponsored by University of Connecticut.
NCT05110963 is a NA study of HIV I Infection that is active but no longer recruiting, run by University of Connecticut. The registered enrollment target is 3,771 participants, above the 1,350-participant average among 5 other HIV I Infection trials with a reported enrollment target (179% higher). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05110963, a NA study of HIV I Infection, is active but no longer recruiting, sponsored by University of Connecticut.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 3,771 participants
- Enrollment target
- 2
- Study locations
Study Summary
Retention in care and persistent adherence to antiretroviral therapy are necessary for the successful treatment of HIV infection. HIV-related stigma is a known impediment to the care and health outcomes of people living with HIV. The proposed study will test theory-based interventions designed to manage HIV stigma in order to improve care retention and medication adherence in communities with high-levels of HIV-related stigma.
Primary Outcome
Medical records are retrospectively collected for all scheduled care visits and coded for whether the visits were attended.The records are exclusively from the clinic where patients are initially recruited and with patient permission. The data obtained are expressed as the ratio of the number of care appointments attended relative to the number scheduled.
Conditions Studied
Interventions
- BEHAVIORAL Uniform Standard of Care Counseling
- BEHAVIORAL Behavioral Self-Regulation Skills Counseling
- BEHAVIORAL Behavioral Self-Regulation Skills Counseling + Stigma Management
Study Locations (2)
Connecticut
- University of Connecticut - Storrs
Georgia
- University of Connecticut Field Site - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,771 participants |
| Start Date | 2021-02-01 |
| Est. Completion | 2026-11-01 |
| Phase | NA |
What the registry record for NCT05110963 still lists
NCT05110963 is an interventional study that assigns participants to a tested intervention. Its 3,771 participants enrollment target places it among the larger protocols in the corpus, above the 1,350-participant average among 5 other HIV I Infection trials with a reported enrollment target (179% higher).
The record links to 1 condition, with HIV I Infection appearing as the primary indexed condition, and to 3 interventions - of which Uniform Standard of Care Counseling is the first listed.
NCT05110963 reports a single indexed study location in Connecticut, Georgia.
Frequently Asked Questions
What is clinical trial NCT05110963 about?
NCT05110963 is a clinical study titled "Intervention to Improve HIV Care Retention by Addressing Stigma Stigmatized Environments". Retention in care and persistent adherence to antiretroviral therapy are necessary for the successful treatment of HIV infection. HIV-related stigma is a known impediment to the care and health outcomes of people living with HIV. The proposed study will test theory-based interventions designed to ma...
What is the current status of trial NCT05110963?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 3,771 participants. The study started on 2021-02-01. Estimated completion is 2026-11-01.
What conditions does trial NCT05110963 study?
This clinical trial studies the following conditions: HIV I Infection.
What interventions are being tested in trial NCT05110963?
The interventions under investigation include: Uniform Standard of Care Counseling (BEHAVIORAL), Behavioral Self-Regulation Skills Counseling (BEHAVIORAL), Behavioral Self-Regulation Skills Counseling + Stigma Management (BEHAVIORAL).
Who is sponsoring clinical trial NCT05110963?
This trial is sponsored by University of Connecticut, which has 107 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05110963 being conducted?
This trial has 2 study locations across Connecticut, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV I Infection
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Acute Effects of TCIG vs ECIG in PLWH
COMPLETED · NA
-
To Investigate Safety, Reactogenicity and Immunogenicity of VIR-1388 Compared With Placebo in Participants Without HIV
COMPLETED · Phase 1
-
VIR-1111: A Prototype Human CMV-based Vaccine for Human Immunodeficiency Virus (HIV) in Healthy Volunteers
COMPLETED · Phase 1
-
Charlotte Retention in Care Study
COMPLETED
-
Estradiol Therapy In Transgender Women to Research Interactions With HIV Therapy
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04573660 · 3,784 participants
Abbott Vascular Medical Device Registry
- NCT06172660 · 3,750 participants
Real-World Effectiveness of Perinatal RSV Immunoprophylaxis
- NCT06298253 · 3,750 participants · NA
Behavioral Economics to Implement a Traffic Light Nutrition Ranking System: Study 2
- NCT06076304 · 3,720 participants · Phase 4
Nasal Steroids, Irrigation, Oral Antibiotics, and Subgroup Targeting for Effective Management of Acute Sinusitis
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI